Friday, 05 June, 2020

Scientists recruiting over-55s for vaccine trial

Partner institutions across Britain had started recruiting up to 10,260 adults and children UK: Oxford vaccine goes to human trials' next phase
Ginger Lawrence | 24 May, 2020, 00:32

The vaccine was based on a cold virus called Ad5, modified to carry genetic instructions to the human cell to help make a coronavirus protein, which the immune system attacks to help keep people from becoming overwhelmed by COVID-19, according to The Lancet.

Last month, scientists at Oxford University began immunizing more than 1,000 volunteers with their vaccine candidate in a preliminary trial created to test the shot's safety.

Fox News has reached out to Oxford University and the Medicines and Healthcare products Regulatory Agency with a request for comment. On Friday, the scientists announced they now aim to vaccinate 10,260 people across Britain, including older people and children.

Dr. Anthony Fauci made a series of positive comments about Moderna's early COVID-19 vaccine data in interviews on Thursday night and Friday morning, sending shares higher by more than 5% on Friday. Stage 3 of the trials will include studying the vaccine's performance in bodies of a large count of adults, aged 18 years and above.

"AstraZeneca recognises that the vaccine may not work but is committed to progressing the clinical program with speed and scaling up manufacturing at risk", it said.

He has also urged Americans to try unproven treatments for COVID-19, such as the malaria drug hydroxychloroquine, which he said on Monday he has taken for weeks despite warnings about its use from the FDA and other health experts. "How quickly we reach the numbers required will depend on the levels of virus transmission in the community".

Donald Trump To Attend Florida Launch Of SpaceX Flight: White House
Rhode Island Governor Gina Raimondo said that churches would still reopen on May 30th, as previously scheduled. The presidential face mask Donald Trump refused to wear.

Earlier this week, the U.K.'s Business Secretary Alok Sharma said that the Oxford vaccine trial, if successful, could deliver 30 million doses by September.

A number of efforts to develop a coronavirus vaccine are underway around the world.

She said: "This is an incredibly important study to be involved in and we are delighted to be able to utilise the fantastic respiratory infection expertise that we have within our team at LSTM, and across Liverpool and Merseyside to make a vital contribution from the Northwest to this UK-wide phase of this pivotal clinical trial".

As of Friday morning, more than 5.12 million coronavirus cases have been diagnosed worldwide, at least 1,577,785 of which are in the USA, according to data compiled by Johns Hopkins University.

Fox News' Christopher Carbone contributed to this article.